TY - JOUR T1 - Evaluation of the Thoracic Revised Cardiac Risk Index as a prognostic factor for survival after lung cancer resection JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.congress-2018.PA2798 VL - 52 IS - suppl 62 SP - PA2798 AU - Teresa Diaz De Teran Lopez AU - Cristina Magadan Alvarez AU - Kimberley Lee AU - Pablo Lozano Cuesta AU - Victoria Maderuelo Garcia AU - Victor Mora Cuesta AU - David Iturbe Fernandez AU - Beatriz Abascal Bolado AU - Laura Sanchez Moreno Y1 - 2018/09/15 UR - http://erj.ersjournals.com/content/52/suppl_62/PA2798.abstract N2 - To evaluate if ThRCRI is an independent prognostic factor for survival after lung cancer resection (LCR)Retrospective analysis of patients undergoing major lung resection for lung cancer between 2005-2016. Data relating to patient demographics, clinical features, treatment and outcome were recorded. ThRCRI was calculated for each patient, with patients stratified into four classes according to their total score:0(Class A),1-1.5 (B),2.5 (C) and >2.5(D). Kaplan-Meier curves were calculated for ThRCRI Class A and B, C and D (the latter classes were combined into a single due to small number in C and D). Survival was estimated using Hazard Ratios(HR) at 60 and 140 months. Cox regression analysis was carried out utilising the variables age, sex, FEV1%predicted, TNM stage and body mass index;these variables were selected by backwards selection with automatic methods587 patients (mean age 64.1; 80.4% male)underwent lobectomy(89%)or pneumonectomy for lung cancer(40.7% adenocarcinoma, 41.4% squamous cell carcinoma). Patients in ThRCRI Class A had increased survival at 60 months(82%) and 140(70%)compared to B, C and D. Univariate Cox analysis of ThRCRI produced a hazard ratio of 1.8(p<0.002); however, HR was not maintained as an independent prognostic factor following multivariate analysisPatients in ThRCRI Class A have increased survival. However, ThRCRI is not an independent prognostic factor of survival following LCR FootnotesCite this article as: European Respiratory Journal 2018 52: Suppl. 62, PA2798.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only). ER -